DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

DAE HWA Pharmaceutical Revenue

DAE HWA Pharmaceutical had revenue of 41.29B KRW in the quarter ending June 30, 2026, with 14.82% growth. This brings the company's total for the last twelve months to 148.75B, up 0.14% year-over-year. In the year 2025, DAE HWA Pharmaceutical had annual revenue of 143.06B, down -4.25%. That makes DAE HWA Pharmaceutical the 21,774th largest company in the world by revenue and 1,202nd in South Korea.

• Revenue (ttm): 148.75B
• Revenue Growth: +0.14%
• P/S Ratio: 1.23
• Revenue / Employee: 482.97M
• Employees: 308
• Market Cap: 182.93B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Manufacturing Industry 105.29B 67.7%
• Pharmaceutical Wholesale Business 24.26B 15.6%
• Pharmaceutical Raw Materials Manufacturing 17.84B 11.5%
• Cosmetic and medical device manufacturing and sales 7.90B 5.1%
• Medical Information System 285.82M 0.2%

By Geography

Chart

• The Republic of Korea 126.30B 88.3%
• Germany 5.51B 3.8%
• Myanmar / Cambodia 2.98B 2.1%
• China 2.95B 2.1%
• Vietnam 2.12B 1.5%
• Ecuador/Bolivia 1.77B 1.2%
• Others 1.43B 1.0%

Fiscal year ended Dec 31, 2025 See the full DAE HWA Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	143.06B	-6.35B	-4.25%
Dec 31, 2024	149.41B	8.05B	5.69%
Dec 31, 2023	141.36B	9.45B	7.16%
Dec 31, 2022	131.91B	14.75B	12.59%
Dec 31, 2021	117.16B	7.81B	7.15%

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error